Kehoe Law Firm, P.C. is investigating potential securities fraud claims on behalf of investors of Hub Group, Inc. (“Hub Group”) (NASDAQ: HUBG).

On March 12, 2026, Hub Group reported that “. . . the previously issued audited consolidated financial statements of the Company as of and for each of the years ended December 31, 2024 . . . and 2023 . . . included in the Company’s Annual Reports on Form 10-K filed on February 25, 2025 and February 27, 2024, respectively, were in each case materially misstated and should no longer be relied upon. Any previously furnished or filed reports, earnings releases, investor presentations or similar communications of the Company describing the 2024 Financial Statements or the 2023 Financial Statements (or any portion thereof) should no longer be relied upon.”

On this news, shares of Hub Group stock dropped and were down more almost 9% during intraday trading on May 12, 2026.

Hub Group Investors May Have Legal Claims

Hub Group investors with financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential breach of fiduciary duty claims to determine whether KinderCare Learning Companies, Inc. (“KinderCare”) (NYSE: KLC) failed to manage KinderCare in an acceptable manner and whether KinderCare and its shareholders were harmed as a result.

In March 2026, U.S. Senator Jeff Merkley announced an “[i]nvestigation seek[ing] to determine if private equity ownership in the child care industry is prioritizing investor profits over the health, safety, and welfare of children.”

Senator Merkley “. . . launched an investigation into the two largest private equity controlled child care companies serving collectively over 365,000 children, KinderCare Learning Companies and Learning Care Group, as well as their respective private equity owners.”

Senator Merkley “. . . is calling on these companies to provide information and documents, such as financial records, ownership structure, tuition and cost trends, safety standards, and employment practices to better understand the effects of private equity ownership in the child care sector.”

KinderCare Investors May Have Legal Claims

KinderCare investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential breach of fiduciary duty claims to determine whether Reddit, Inc. (NYSE: RDDT) failed to manage Reddit in an acceptable manner and whether Reddit and its shareholders were harmed as a result.

In February 2026, the UK Information Commissioner’s Office (“ICO”) fined Reddit £14.47 million (approximately $19.5 million) after finding that Reddit:

“Failed to apply any robust age assurance mechanism and therefore did not have a lawful basis for processing the personal information of children under the age of 13.”

“Failed to carry out a data protection impact assessment . . . to assess and mitigate risks to children before January 2025.”

“These failures meant Reddit was using children’s data unlawfully, potentially exposing them to inappropriate and harmful content.”

Reddit Investors May Have Legal Claims

Reddit investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQ: ADMA).

On May 6, 2026, ADMA Biologics reported that “[b]eginning in the second half of 2025 and continuing into the first quarter of 2026, new FDA-approved IVIG products, and other pharmaceutical products which compete with certain IVIG product uses, entered the market with aggressive pricing tactics, including extended payment terms, rebates and discounts. This has led to increases in raw material plasma supply and finished goods inventory across the distribution network. This created competitive intensity and distribution recalibration across the industry which impacted [ADMA Biologics’] first quarter of 2026 results, mainly as it relates to BIVIGAM, but broadly across the IVIG complex. If this trend of competitive pricing tactics continues, future results and penetration for [its] products may be adversely impacted.”

Following this news, ADMA Biologics’ stock price fell sharply in after-hours trading on May 6, 2026 and declined more than 21% in pre-market trading on May 7, 2026.

The Company’s disclosure follows a March 2026 Culper Research report which stated, among other things, that “. . . ADMA’s reported growth is a fiction driven more than entirely by a de facto channel stuffing scheme and an undisclosed related party distributor.”

ADMA Biologics Investors May Have Legal Claims

ADMA Biologics investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Medline, Inc. (“Medline”) (NASDAQ: MDLN).

In a March 25, 2026 Warning Letter, the FDA cited Medline Industries’ NAMIC Division for quality-system and manufacturing deficiencies involving angiographic control syringes and cardiovascular procedure kits manufactured in Glens Falls, New York.

The FDA alleged that Medline failed to adequately address increasing complaints beginning in 2023 regarding syringe disconnections that the company attributed to excess silicone, including 221 complaints and 177 medical device reports, one involving air injected into a patient and another involving clinician biohazard exposure. The FDA also cited deficiencies involving equipment cleaning, contamination controls, and design verification, concluding that the devices were “adulterated” under the Federal Food, Drug, and Cosmetic Act because Medline’s manufacturing controls did not comply with Quality System regulations.

The FDA warned Medline that failure to promptly correct the violations could result in enforcement actions including seizure, injunction, and civil money penalties.

After Medline reported Q1 earnings on May 6, 2026, Medline’s stock price was down more than 7% during intraday trading.

Medline Investors May Have Legal Claims

Medline investors are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Cogent Communications Holdings, Inc. (“Cogent Communications” or the “Company”) (NASDAQ: CCOI).

Cogent Communications’ stock declined sharply on May 4, 2026, after the Company reported that its “. . . service revenue decreased by 3.2% from the three months ended March 31, 2025 to the three months ended March 31, 2026.” The Company further disclosed, among other things, that its “. . . total service revenue decreased from the cancellation of low margin and non-core customers [it] acquired with the Cogent Fiber Business . . ..”

On this news, Cogent Communications stock dropped to $16.37 per share, closing down 29.32% on May 4, 2026.  

Cogent Communications Investors May Have Legal Claims

Investors of Cogent Communications with financial losses are encouraged to complete Kehoe Law Firm’s Stockholder Information Request Form or contact Michael Yarnoff, Esq., (215) 792-6676, Ext. 804, [email protected], [email protected], to learn more about the investigation and receive a free, no-obligation evaluation of potential legal claims.  

About Kehoe Law Firm, P.C.

Kehoe Law Firm, P.C. is a nationally recognized, plaintiff-side class action firm dedicated to protecting investors and consumers from fraud and misconduct. Our attorneys have served as Lead or Co-Lead Counsel in major securities cases, recovering over $10 billion for institutional and individual investors.

Our firm litigates securities fraud, fiduciary breaches, unfair mergers and acquisitions, and antitrust violations, while also representing whistleblowers and advocating for victims of data breaches, consumer fraud, vehicle and product defects, employment law violations, retirement plan mismanagement, and other corporate and business misconduct. With a results-driven approach, we pursue justice and substantial recoveries for those we represent.

Kehoe Law Firm’s class action legal services are provided on a contingency-fee basis, meaning clients are not responsible for any fees or litigation expenses.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]